Ausgabe 1/2018
Inhalt (33 Artikel)
Socioeconomic status and breast cancer treatment
Marie S. Dreyer, Ann B. Nattinger, Emily L. McGinley, Liliana E. Pezzin
Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis
Alberto Gallardo, Barbara Garcia-Valdecasas, Paola Murata, Rolando Teran, Laura Lopez, Agusti Barnadas, Enrique Lerma
Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer
Mariko Kochi, Takayuki Iwamoto, Naoki Niikura, Giampaolo Bianchini, Shinobu Masuda, Taeko Mizoo, Tomohiro Nogami, Tadahiko Shien, Takayuki Motoki, Naruto Taira, Yutaka Tokuda, Hiroyoshi Doihara, Junji Matsuoka, Toshiyoshi Fujiwara
Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing
Nanae Masunaga, Naofumi Kagara, Daisuke Motooka, Shota Nakamura, Tomohiro Miyake, Tomonori Tanei, Yasuto Naoi, Masafumi Shimoda, Kenzo Shimazu, Seung Jin Kim, Shinzaburo Noguchi
Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials
Marion T. van Mackelenbergh, Carsten Denkert, Valentina Nekljudova, Thomas Karn, Christian Schem, Frederik Marmé, Elmar Stickeler, Christian Jackisch, Claus Hanusch, Jens Huober, Peter A. Fasching, Jens-Uwe Blohmer, Sherko Kümmel, Volkmar Müller, Andreas Schneeweiss, Michael Untch, Gunter von Minckwitz, Karsten E. Weber, Sibylle Loibl
An observational study investigating failure of primary endocrine therapy for operable breast cancer in the elderly
Robert Thomas, Rachel Rowell, Siobhan Crichton, Henry Cain
Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis
Naoki Niikura, Akihiko Shimomura, Yumi Fukatsu, Masataka Sawaki, Rin Ogiya, Hiroyuki Yasojima, Tomomi Fujisawa, Mitsugu Yamamoto, Michiko Tsuneizumi, Akira Kitani, Junichiro Watanabe, Akira Matsui, Yuko Takahashi, Seiki Takashima, Tadatoshi Shien, Kenji Tamura, Shigehira Saji, Norikazu Masuda, Yutaka Tokuda, Hhiroji Iwata
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
Roberto A. Leon-Ferre, Mei-Yin Polley, Heshan Liu, Judith A. Gilbert, Victoria Cafourek, David W. Hillman, Ahmed Elkhanany, Margaret Akinhanmi, Jenna Lilyquist, Abigail Thomas, Vivian Negron, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, Daniel W. Visscher, Matthew P. Goetz
Characteristics and prognosis of breast cancer after liver or kidney transplantation
I-Ji Jeong, Sung-Gyu Lee, Young Hoon Kim, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Se-Hyun Ahn, Hee Jeong Kim
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008
Roisin M. Connolly, Mary Jo Fackler, Zhe Zhang, Xian C. Zhou, Matthew P. Goetz, Judy C. Boughey, Bridget Walsh, John T. Carpenter, Anna Maria Storniolo, Stanley P. Watkins, Edward W. Gabrielson, Vered Stearns, Saraswati Sukumar
Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy
Brooke A. Rice, Elizabeth S. Ver Hoeve, Amy N. DeLuca, Laura J. Esserman, Hope S. Rugo, Michelle E. Melisko
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial
G. Viale, F. A. de Snoo, L. Slaets, J. Bogaerts, L. van ’t Veer, E. J. Rutgers, M. J. Piccart-Gebhart, L. Stork-Sloots, A. Glas, L. Russo, P. Dell’Orto, K. Tryfonidis, S. Litière, F. Cardoso
Obesity, physical activity, and breast cancer survival among older breast cancer survivors in the Cancer Prevention Study-II Nutrition Cohort
Maret L. Maliniak, Alpa V. Patel, Marjorie L. McCullough, Peter T. Campbell, Corinne R. Leach, Susan M. Gapstur, Mia M. Gaudet
Non-visualized sentinel nodes in breast cancer patients; prevalence, risk factors, and prognosis
N. C. Verheuvel, A. C. Voogd, V. C. G. Tjan-Heijnen, S. Siesling, R. M. H. Roumen
Chronic pain and other symptoms among breast cancer survivors: prevalence, predictors, and effects on quality of life
Rola Hamood, Hatem Hamood, Ilya Merhasin, Lital Keinan-Boker
Healthy lifestyle impact on breast cancer-specific and all-cause mortality
Adaline E. Heitz, Richard N. Baumgartner, Kathy B. Baumgartner, Stephanie D. Boone
Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes
Ebtihag O. Alenzi, S. Suresh Madhavan, Xi Tan
Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs
Anna N. A. Tosteson, Qian Yang, Heidi D. Nelson, Gary Longton, Samir S. Soneji, Margaret Pepe, Berta Geller, Patricia A. Carney, Tracy Onega, Kimberly H. Allison, Joann G. Elmore, Donald L. Weaver
Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients
M. L. Gregorowitsch, H. J. G. D. van den Bongard, D. A. Young-Afat, J. P. Pignol, C. H. van Gils, A. M. May, H. M. Verkooijen
Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer
Gabrielle B. Rocque, Courtney P. Williams, Meredith I. Jones, Kelly M. Kenzik, Grant R. Williams, Andres Azuero, Bradford E. Jackson, Karina I. Halilova, Karen Meneses, Richard A. Taylor, Ed Partridge, Maria Pisu, Elizabeth A. Kvale
Take care of your neighborhood
Elmer E. Huerta, Patricia Weeks-Coulthurst, Courtney Williams, Sandra M. Swain
Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else?
Kirsten A. Nyrop, Allison M. Deal, Jordan T. Lee, Hyman B. Muss, Seul Ki Choi, Amy Wheless, Lisa A. Carey, Shlomit S. Shachar
Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients
Sara Ruiz-Pinto, Guillermo Pita, Miguel Martín, Teresa Alonso-Gordoa, Daniel R. Barnes, María R. Alonso, Belén Herraez, Purificación García-Miguel, Javier Alonso, Antonio Pérez-Martínez, Antonio J. Cartón, Federico Gutiérrez-Larraya, José A. García-Sáenz, Javier Benítez, Douglas. F. Easton, Ana Patiño-García, Anna González-Neira
Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? An HMO perspective
Nava Siegelmann-Danieli, Itzhak Katzir, Janet Vesterman Landes, Yaakov Segal, Rachel Bachar, Hadas Rotem Rabinovich, Martin Bialik, Joseph Azuri, Avi Porath, Yossef Lomnicky
The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy
Vasily Giannakeas, Steven A. Narod
Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing
David C. Lin, Jonathan R. Genzen
Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population
Ying L. Liu, Anurag Saraf, Benjamin Catanese, Shing M. Lee, Yuan Zhang, Eileen P. Connolly, Kevin Kalinsky
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research
Jodi M. Saunus, Chanel E. Smart, Jamie R. Kutasovic, Rebecca L. Johnston, Priyakshi Kalita-de Croft, Mariska Miranda, Esdy N. Rozali, Ana Cristina Vargas, Lynne E. Reid, Eva Lorsy, Sibylle Cocciardi, Tatjana Seidens, Amy E. McCart Reed, Andrew J. Dalley, Leesa F. Wockner, Julie Johnson, Debina Sarkar, Marjan E. Askarian-Amiri, Peter T. Simpson, Kum Kum Khanna, Georgia Chenevix-Trench, Fares Al-Ejeh, Sunil R. Lakhani
Predictive role of loco-regional radiotherapy among metastatic breast cancer patients who had undergone primary tumor surgery
Kadri Altundag
A frameshift mutation in BRCA1 leads to hereditary breast and ovarian cancer in one part of a family and to familial pancreatic cancer in another
Laura Gieldon, Johannes Wagner, Andreas Rump
Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients
Carlo Palmieri, Rob C. Stein, Xinxue Liu, Emma Hudson, Hanna Nicholas, Hironobu Sasano, Fouzia Guestini, Chris Holcombe, Sophie Barrett, Laura Kenny, Sadie Reed, Adrian Lim, Larry Hayward, Sacha Howell, R. Charles Coombes